Selective TBK1/IKKi dual inhibitors with anticancer potency.
about
Identification of Novel Inhibitors of the Type I Interferon Induction Pathway Using Cell-Based High-Throughput ScreeningDetection of IKKε by immunohistochemistry in primary breast cancer: association with EGFR expression and absence of lymph node metastasis.Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways.Integrin-mediated resistance to epidermal growth factor receptor-targeted therapy: an inflammatory situation.TBK1 inhibitors: a review of patent literature (2011 - 2014).Therapeutic potential of targeting TBK1 in autoimmune diseases and interferonopathies.IκB-Kinase-epsilon (IKKε) over-expression promotes the growth of prostate cancer through the C/EBP-β dependent activation of IL-6 gene expression.Inflammation and NF-κB Signaling in Prostate Cancer: Mechanisms and Clinical ImplicationsRoles for the IKK-Related Kinases TBK1 and IKKε in Cancer
P2860
Q27469008-89EFE5DA-3102-4D23-BA21-6AB0CCF65F81Q33717414-B4FD9572-734B-42F0-B82D-17BD370E1684Q35624305-0FFBC063-73D4-41F7-A087-0888B52E2D5FQ36507879-09E76C61-915A-44AB-910D-766B57AD8E6DQ38570615-B0FCFAF4-4A72-4CFC-9921-00BF6F847DDEQ38879970-1981B82F-656A-4D97-A3A5-0DF2BACCD5FEQ42314708-CAE000FE-1BA3-44D7-ACC6-F9528453074EQ57107409-466C1FE9-953E-4914-9F8A-3BB605E66F12Q58737053-1691560B-B25E-401F-9378-2DF2B2ED317C
P2860
Selective TBK1/IKKi dual inhibitors with anticancer potency.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Selective TBK1/IKKi dual inhibitors with anticancer potency.
@en
Selective TBK1/IKKi dual inhibitors with anticancer potency.
@nl
type
label
Selective TBK1/IKKi dual inhibitors with anticancer potency.
@en
Selective TBK1/IKKi dual inhibitors with anticancer potency.
@nl
prefLabel
Selective TBK1/IKKi dual inhibitors with anticancer potency.
@en
Selective TBK1/IKKi dual inhibitors with anticancer potency.
@nl
P2093
P2860
P356
P1476
Selective TBK1/IKKi dual inhibitors with anticancer potency.
@en
P2093
Ji-Hak Jeong
Jieying Peng
Jingjia Huang
Jun-Li Luo
Sun-Jin Park
Yangbo Feng
Yen Ting Chen
Zhiyong Luo
P2860
P304
P356
10.1002/IJC.28507
P577
2013-10-21T00:00:00Z